<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
OR 15d-17 THEREUNDER
Lifecore Biomedical, Inc.
------------------------------------------------
(Exact name of issuer as specified in charter)
3515 Lyman Boulevard, Chaska, MN 55318-3051
----------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code: (612) 368-4300
--------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding.
1. Title of security: Common Stock, $.01 Par Value Per Share
--------------------------------------------------------
2. Number of shares outstanding before the change: 10,612,041
---------------------------
3. Number of shares outstanding after the change: 12,112,041
----------------------------
4. Effective date of change: April 11, 1996
-------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.): Private Offering
----------------
Give brief description of transaction: The Company sold 1,500,000 shares of
------------------------------------
newly issued common stock in a Regulation S Offering.
- --------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change:
-----------------------------------------------------
2. Name after change:
--------------------------------------------------------
3. Effective date of charter amendment changing name:
------------------------
4. Date of shareholder approval of change, if required:
----------------------
Date: April 15, 1996 /s/ Dennis J. Allingham
--------------------- ----------------------------------------------
Dennis J. Allingham, Chief Financial Officer
(Officer's signature & title)
